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16 years after the discovery of the CFTR gene, more than 1400 anomalies were 
described in the world, the majority of them being single base-pair substitutions 
or micro-insertions/deletions, but more and more gross rearrangements have been 
recently characterized, ue to novel techniques of quantitative PCR such as the 
quantitative multiplex polymerase chain reaction of short fluorescent fragments 
(QMPSF). 
With this technique, we first performed a systematic analysis of the 27 exons of 
the gene, and found that about 20% of previously unidentified CF chromosomes 
(after extensive and complete screening of the gene by both denaturing gradient gel 
electrophoresis (DGGE) and denaturing high-performance liquid chromatography 
(DHPLC)) carried a gross rearrangement. 
In emergency situations, such as the discovery of an hyperechogenic bowel during 
pregnancy, when a mutation is transmitted to the foetus, the residual risk of 
mucoviscidose is very high, close to 1/10 according to the ethnic origin of the 
patients and the cover rate obtained. The laboratories must thus make efforts as 
soon as possible to analyze the totality of the anomalies of the gene. 
That is why we developed a rapid strategy, which allows the search for these great 
rearrangements on the totality of the 27 exons of the gene into 2 PCR-multiplex 
coupled with a single analysis on capillary sequencer. This technique is simple, 
fast (the results can be obtained within 24 hours) and was validated on 20 samples 
carrying reat rearrangements identified in the laboratory. 
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Introduction: CF is caused by mutations in the CFTR gene. However, even the 
most advanced mutation detection methods designed for CFTR promoter, coding 
region and splicing junctions fail to identify all mutations in most CF populations. 
We hypothesize that a subset of disease-causing mutations occur in yet unknown 
intronic regulatory cis-elements in the CFTR locus. The potential candidate regions 
containing these elements are DNAse Hypersensitive Sites (DHS) and highly 
conserved intronic (HCI) regions. Here we report preliminary data from our study 
aiming at characterization f DNA variants in these regions. 
Methods: 25 well defined DHS sites and 24 HCI regions (homology alignment 
of 11 CFTR orthologs) were selected for the study. These regions were screened 
for DNA variants as 72 PCR fragments using multiplex heteroduplex analysis and 
direct sequencing. The analysis was performed on 151 CF patients of whom 97 
carried incomplete CFTR genotype after a complete screening of promoter, coding 
region and splicing junctions. 
Results and Conclusions: All PCR fragments representing the selected CFTR 
gene regions were screened. In total, at least 18 SNP variants (10 in DHS and 
8 in HCI fragments) were detected in the tested cohort. Overall frequency of these 
variants ranged from 0.6 to 38%. Although the number of studied patients was 
relatively small it appeared that some variants occur more frequently in patients 
with incomplete genotypes (e.g. in 31 4574+6.8kb or Intron17a 3271+1kb regions). 
These variants will be further analyzed in the extended CF cohorts. 
Support: Canadian Cystic Fibrosis Foundation. 
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Aims: The aim of our study was the development of a reliable and simple real-time 
PCR assay which allows the detection of large deletions in the CFTR gene. The 
frequency of large deletions in CF patients is estimated to be 1 3%, being more 
frequent han most of the known point mutations. Another important goal was 
the establishment of genotype-phenotype associations in CF patients with newly 
identified large deletions. 
Material and Methods: In a first step we designed the first assay based on 
quantitative r al-time PCR that allows reliable and accurate detection of the copy 
number of all 27 exons of the CFTR gene. In a second step, using the CFTR 
MLPA ® Kit (MRC Holland) we performed a deletion screening of 52 patients with 
only one detectable mutation. Detected eletions were confirmed by our real-time 
PCR assay. 
Results: The results obtained from measurements of normal control individuals and 
patients with known large deletions how that our assay allows an exact and rapid 
detection of the copy number of all 27 exons of the CFTR gene and represents an 
alternative method to MLPA ® or QMPSF, especially in terms of specific testing. For 
the MLPA ® screening we found large deletions in 8 patients which can be grouped 
into four different deletions types (indel2, dele2 9, dele14b 17b, dele17a 17b), 
including a new deletion spanning exon 2 9. 
Conclusion: The detection rate in our study (15.6%) and previous tudies (15 25%) 
demonstrate that screenings for large deletions in the CFTR gene should be 
integrated in CF mutation analysis especially in patients with only one detected 
mutation. In addition the clinics of patients who are compound heterozygous for a 
point mutation and a large deletion allowed new genotype-phenotype associations 
that are of prognostic value. 
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Introduction: Hepatobiliary disease includes: liver disease, neonatal cholestasis, 
cholelithiasis, microgallbladder, common bile duct stenosis. Liver disease is asso- 
ciated with male gender, history of meconium ileus and severe genotype; therefore 
questions concerning a genotype~henotype correlation arise. 
Aim of the study: to evaluate the genotype~henotype correlation in patients with 
CF associated liver disease. 
Study group and Methods: 85 patients were followed up by clinical assessment, 
biochemical markers, ultrasound examinations and liver biopsy in some cases. All 
were genetically tested using ElucigeneTM CF29 kit. 
Results: Hepatobiliary disease was diagnosed in 36 patients (42.35%). Among 
56 children younger than 10 years, only 11.76% of them had liver disease, 
2 associating neonatal cholestasis (both being AF508 homozygous). 30.59% of 
children (older than 10 years) had hepatobiliary expression; in about 9% (8 children) 
of them multilobular cirrhosis was diagnosed, in 4 cases confirmed by biopsy. 
Genotype structure of 85 patients revealed 32 AF508 homozygous genotypes, 
22 AF508/X, 5 non-AF508/X and 26 unknown (X/X), the frequency of AF508 allele 
being 50.58%. Severe liver disease developed in 6 patients: 4 children with AF508 
homozygous genotype, 1 with 2183AA>G/621+lG>T, 1 with AF508/G542X. 
Among AF508 homozygous patients only 15.29% had hepatobiliary disease. 
Conclusion: No specific correlation between phenotype and a specific mutation 
has been identified. The heterogeneous phenotypes in CF patients having the same 
genotype suggest that other environmental nd/or genetic factors are involved. 
